Advanced Drug Delivery Systems for Targeted Immunotherapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 August 2025) | Viewed by 410
Special Issue Editors
2. Materials Research and Education Center, Materials Engineering, Department of Mechanical Engineering, Auburn University, Auburn, AL 36849, USA
Interests: pharmaceutical science; cancer; inflammatory disease; nanomedicines; nanoparticles
Interests: long-acting drug delivery; liposomes; immunotherapy; oral absorption; ophthalmic preparations
Special Issue Information
Dear Colleagues,
Immunotherapy represents a transformative approach in the treatment of various cancers, leveraging the body's immune system to target and destroy tumor cells. However, the efficacy of immunotherapy is often hindered by challenges such as off-target effects, poor drug stability, and inadequate delivery to tumor sites. Recent advancements in drug delivery systems, particularly those utilizing nanotechnology, offer promising solutions to these challenges.
This Special Issue aims to explore the latest developments and innovations in advanced drug delivery systems designed specifically for targeted immunotherapy. We invite original research papers, comprehensive reviews, and short communications that address the following areas:
- Novel nanocarrier systems for the targeted delivery of immunotherapeutic agents;
- Strategies to enhance the stability and bioavailability of immunotherapeutics;
- Innovations in personalized drug delivery systems for immunotherapy;
- Overcoming barriers to effective tumor targeting and minimizing off-target effects;
- Preclinical and clinical advancements in drug delivery for immunotherapeutic applications.
We are eager to gather high-quality contributions that advance our understanding and application of sophisticated drug delivery technologies in immunotherapy.
We look forward to your valuable contributions.
Dr. Xuejia Kang
Prof. Dr. Yongjun Wang
Prof. Dr. Peng Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery systems
- Immunotherapy
- nanocarrier
- bioavailability
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
